Colon Cancer News
Antibiotic Sponge Ineffective at Preventing Surgical Infection (August 12, 2010)Patients undergoing colorectal surgery are reported to experience an increased incidence of surgical-site infection with the addition of a gentamicin-collagen sponge enclosed at the surgery site. These findings were recently published in the New England... Continue Reading
Screening Rates Among Older Americans (July 15, 2010)More older Americans are undergoing screening for colon cancer, but the rates for breast cancer screening remain the same, according to a government report released on July 6, 2010.[1] The best “treatment” of cancer is preventing its occurrence in... Continue Reading
Radioembolization plus Fluorouracil Active in Colorectal Cancer Patients with Liver Metastases (July 2, 2010)Radioembolization plus the chemotherapy agent fluorouracil slows cancer progression for colorectal cancer patients whose disease has progressed following prior treatment with chemotherapy and have metastases limited to the liver. These findings were recently... Continue Reading
Potential Role for Oncotype DX Colon Cancer Test in Stage III Cancer (June 10, 2010)The Oncotype DX® colon cancer test, which is currently available for treatment planning in Stage II colon cancer, may also predict recurrence risk in Stage III colon cancer. These results were presented at the 2010 annual meeting of the American Society... Continue Reading
Erbitux Does Not Improve Survival in Stage III Colon Cancer with Normal KRAS (June 8, 2010)The addition of Erbitux® (cetuximab) to standard adjuvant chemotherapy in patients with stage III colon cancer who have normal KRAS gene activity does not improve survival, according to the results of a Phase III study presented at the 2010 annual meeting... Continue Reading
Optimal Outcomes with Vascular Endothelial Growth Factor (VEGF) Inhibitors Require Appropriate Hypertension Assessment, Monitoring, and Management (May 28, 2010)An expert panel provided consensus recommendations for appropriate prevention, surveillance and treatment of hypertension (high blood pressure) in patients treated with vascular endothelial growth factor (VEGF) signaling pathway inhibitors. These recommendations... Continue Reading
Depression May Persist With Metastatic Cancer (May 27, 2010)A substantial number of patients with metastatic cancer may suffer from depression which tends to persist and grow more severe toward the end of life, according to the results of a study published early online in the Journal of Clinical Oncology.[1] While... Continue Reading
Rates of Adenoma Detection Linked to Risk of Interval Colorectal Cancer (May 17, 2010)Endoscopists who detect tumors or polyps (adenomas) at a higher rate during colonoscopy screening for colorectal cancer tend to produce a lower risk for interval cancer among their patients, according to a study published in the New England Journal of... Continue Reading
Coffee and Soft Drinks Not Associated with Increased Risk of Colon Cancer (May 12, 2010)Consumption of coffee and sugary soft drinks does not increase the risk of colon cancer, according to the results of a study published early online in the Journal of the National Cancer Institute.[1] High tea consumption, on the other hand, might be... Continue Reading
Colorectal Cancer Screening with Flexible Sigmoidoscopy Reduces Incidence and Death (May 6, 2010)Among individuals between 55 and 64 years of age, one screening using flexible sigmoidoscopy can reduce risk of developing colorectal cancer and dying from the disease, according to a study published in The Lancet. Colon cancer is the second leading... Continue Reading
Latest Colon Cancer News By Stage
Adjuvant (I-III, A-C) Colon Cancer
Antibiotic Sponge Ineffective at Preventing Surgical Infection (August 12, 2010)
Patients undergoing colorectal surgery are reported to experience an increased incidence of surgical-site infection with the addition of a gentamicin-collagen sponge enclosed at the surgery site. These findings were recently published in the New England... Continue Reading
Potential Role for Oncotype DX Colon Cancer Test in Stage III Cancer (June 10, 2010)The Oncotype DX® colon cancer test, which is currently available for treatment planning in Stage II colon cancer, may also predict recurrence risk in Stage III colon cancer. These results were presented at the 2010 annual meeting of the American Society... Continue Reading
Erbitux Does Not Improve Survival in Stage III Colon Cancer with Normal KRAS (June 8, 2010)The addition of Erbitux® (cetuximab) to standard adjuvant chemotherapy in patients with stage III colon cancer who have normal KRAS gene activity does not improve survival, according to the results of a Phase III study presented at the 2010 annual meeting... Continue Reading
Most Survivors of Lung and Colorectal Cancer Keep Their Jobs (April 14, 2010)Among people diagnosed with nonmetastatic lung or colorectal cancer, the majority return to work, according to a study recently published in Journal of Clinical Oncology. Those who do leave the workforce tend to have worse prognoses and lower socioeconomic... Continue Reading
Older Stage III Colon Cancer Patients Not Being Treated According to Evidence-based Recommendations (March 25, 2010)The treatment of Stage III colon cancer does not always follow evidence-based recommendations, especially for older patients, according to the results of an observational study recently published in the Journal of the American Medical Association.[1] Stage... Continue Reading
More Adjuvant (I-III, A-C) Colon CancerScreening/Prevention Colon Cancer
Screening Rates Among Older Americans (July 15, 2010)
More older Americans are undergoing screening for colon cancer, but the rates for breast cancer screening remain the same, according to a government report released on July 6, 2010.[1] The best “treatment” of cancer is preventing its occurrence in... Continue Reading
Rates of Adenoma Detection Linked to Risk of Interval Colorectal Cancer (May 17, 2010)Endoscopists who detect tumors or polyps (adenomas) at a higher rate during colonoscopy screening for colorectal cancer tend to produce a lower risk for interval cancer among their patients, according to a study published in the New England Journal of... Continue Reading
Coffee and Soft Drinks Not Associated with Increased Risk of Colon Cancer (May 12, 2010)Consumption of coffee and sugary soft drinks does not increase the risk of colon cancer, according to the results of a study published early online in the Journal of the National Cancer Institute.[1] High tea consumption, on the other hand, might be... Continue Reading
Colorectal Cancer Screening with Flexible Sigmoidoscopy Reduces Incidence and Death (May 6, 2010)Among individuals between 55 and 64 years of age, one screening using flexible sigmoidoscopy can reduce risk of developing colorectal cancer and dying from the disease, according to a study published in The Lancet. Colon cancer is the second leading... Continue Reading
Lower Use of Diagnostic Testing May Explain Higher Colorectal Cancer Mortality in African Americans (April 6, 2010)The higher incidence and mortality from colorectal cancer among African Americans compared with Whites may be due to differences in health care utilization rather than differences in susceptibility to cancer, according to a study published in the... Continue Reading
More Screening/Prevention Colon CancerStage IV (D)/Relapsed Colon Cancer
Radioembolization plus Fluorouracil Active in Colorectal Cancer Patients with Liver Metastases (July 2, 2010)
Radioembolization plus the chemotherapy agent fluorouracil slows cancer progression for colorectal cancer patients whose disease has progressed following prior treatment with chemotherapy and have metastases limited to the liver. These findings were recently... Continue Reading
Optimal Outcomes with Vascular Endothelial Growth Factor (VEGF) Inhibitors Require Appropriate Hypertension Assessment, Monitoring, and Management (May 28, 2010)An expert panel provided consensus recommendations for appropriate prevention, surveillance and treatment of hypertension (high blood pressure) in patients treated with vascular endothelial growth factor (VEGF) signaling pathway inhibitors. These recommendations... Continue Reading
Depression May Persist With Metastatic Cancer (May 27, 2010)A substantial number of patients with metastatic cancer may suffer from depression which tends to persist and grow more severe toward the end of life, according to the results of a study published early online in the Journal of Clinical Oncology.[1] While... Continue Reading
Study Explores Which Patients Respond Best to Vectibix (April 19, 2010)Previous studies have reported that colorectal cancers with mutations in a gene known as KRAS do not respond well to drugs such as Vectibix® (panitumumab). In an effort to expand these findings and further individualize colorectal cancer treatment,... Continue Reading
Cost Versus Benefit Among Chemotherapy Drugs for Metastatic Colorectal Cancer (March 26, 2010)New chemotherapy agents for metastatic colorectal cancer modestly improve survival time but come with substantial costs, according to the results of a study published in the Archives of Internal Medicine.[1] Metastatic colorectal cancer refers to cancer... Continue Reading
More Stage IV (D)/Relapsed Colon Cancer